Since 2013, the Mohs micrographic surgery workforce has become dominated by fellowship-trained Mohs surgeons; however, a few ...

The process of TIL therapy is complex and requires the coordination of multiple specialties at authorized treatment centers, ...

ChatGPT underdiagnosed malignant skin lesions, signaling an urgent need to educate patients who use AI to triage their ...

Regeneron Pharmaceuticals has won expanded European approval of its blockbuster cancer drug Libtayo for certain patients with skin cancer. Regeneron on Wednesday said the European Commission's nod ...

Approval based on results of landmark Phase 3 C-POST trial that show Libtayo is first immunotherapy to significantly improve disease-free ...

A new study seeks to prevent nonmelanoma skin cancers, reducing the need for invasive treatments such as surgery or ...

Of patients identified as low risk by combined clinicopathological factors and GEP test, only 7.1 percent were SLN-positive.

Studies show certain populations have a higher risk for a certain type of cancer due to the nature of their work.

Study will be Presented at the European Society for Medical Oncology (ESMO) Immuno-Oncology Congress on 10thDecember, 2025 ...

NEO-CYT is a randomized, multi-centre trial of neoadjuvant MDNA11 (before curative intent surgery) sponsored by the Fondazione Melanoma Onlus, ...

About 93% of people classified as low risk by the test had no cancer in their lymph nodes Those folks might be able to skip the biopsy, which requires anesthesia and incisions MONDAY, Oct. 27, 2025 ...

About 93% of people classified as low risk by the test had no cancer in their lymph nodes Those folks might be able to skip the biopsy, which requires anesthesia and incisions ...